The US healthcare system is facing a daunting challenge as a 'super' virus wreaks havoc, leading to a surge in respiratory infections and hospitalizations. But this time, it's not just COVID-19 causing the chaos.
Hospitals are reinstating visitor restrictions reminiscent of the COVID-19 pandemic to combat the alarming rise in flu, COVID, and other respiratory illnesses. This drastic measure aims to prevent the spread of these highly contagious diseases and protect patients and staff.
St. Joseph's/Candler in Georgia is taking a stand against the flu by implementing visitor restrictions. Visitors without a flu shot or exhibiting symptoms must wear masks, and only those over 18 are allowed, unless they are a patient's primary caregiver. Dayton, Ohio, hospitals are following suit, with temporary visitor restrictions starting on December 26 to manage the influx of patients with respiratory illnesses. Visitors with symptoms or under 14 years old are prohibited.
And it's not just visitor restrictions; mask mandates are making a comeback. Major hospital systems in New Jersey, such as Hackensack Meridian Health and RWJ Barnabas Health, have reintroduced mask mandates for staff, patients, and visitors to curb the surge in COVID, flu, and RSV cases. New York State has also mandated masks for unvaccinated healthcare workers in patient areas, as flu cases and hospitalizations have skyrocketed.
But here's where it gets controversial: the flu shot's effectiveness is being questioned. Flu hospitalizations have been on the rise since October, with a sharp spike in November. The CDC estimates over 4.6 million flu illnesses, 49,000 hospitalizations, and 1,900 deaths so far this season. The culprit? The H3N2 subtype of influenza A, which has mutated significantly, evading the immune system's defenses.
Professor Andrew Pekosz from John Hopkins Bloomberg School of Public Health explains that this H3N2 virus is 'evading population immunity,' making more people vulnerable to infection. He adds that while the virus may bypass some vaccine-induced protection, it's not a complete bypass.
The number of positive flu cases is at an all-time high this season, with 927 influenza viruses reported by public health labs last week. Of these, 911 were influenza A, and subtyping revealed that nearly 90% were the notorious H3N2 strain.
Trevor Bedford, a viral evolution expert, warns that H3N2 evolves faster than other influenza strains, predicting more H3 incidence and reduced vaccine effectiveness. This rapid evolution typically occurs every three to four years, catching our immune systems off guard.
The virus has already caused significant damage in Europe, the UK, and Japan, with record-high flu hospitalizations in England. The WHO European Region reports high or very high activity in 27 out of 38 monitored countries. Japan has declared an influenza epidemic, with thousands infected.
Scientists caution that this year's flu shot may provide limited protection due to a mismatch between the vaccine strain and the dominant H3N2 subclade K virus. This mismatch is a significant concern for flu experts, who are closely monitoring the situation as flu activity intensifies across North America.
Health officials emphasize that despite the mismatch, getting a flu shot is still crucial. Even a mismatched vaccine can significantly reduce the risk of severe illness, hospitalization, and death by preparing the immune system to combat the virus family.
Dr. Scott Hensley and Florian Krammer, flu experts, strongly encourage vaccination, stating that this is the year to get the flu vaccine. Krammer adds that last year's H3N2 season may offer some protection, despite the virus's mutations.
As the debate over vaccine effectiveness continues, one thing is clear: the healthcare system is under immense pressure. The 'super' virus is overwhelming hospitals, and the situation is reminiscent of the early days of the COVID-19 pandemic. The question remains: how can we best protect ourselves and our healthcare system from these evolving respiratory threats?
